VENKYS (INDIA)
Back to Balance Sheet
|
VENKYS (INDIA) Last 5 Year Total Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹666 Cr | ₹665 Cr | ₹641 Cr | ₹626 Cr | ₹705 Cr |
What is the latest Total Current Liabilities ratio of VENKYS (INDIA) ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹666 Cr |
Mar2023 | ₹665 Cr |
Mar2022 | ₹641 Cr |
Mar2021 | ₹626 Cr |
Mar2020 | ₹705 Cr |
How is Total Current Liabilities of VENKYS (INDIA) Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹666 Cr | 0.20 | |
Mar2023 | ₹665 Cr | 3.62 | |
Mar2022 | ₹641 Cr | 2.47 | |
Mar2021 | ₹626 Cr | -11.28 | |
Mar2020 | ₹705 Cr | - |
Compare Total Current Liabilities of peers of VENKYS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VENKYS (INDIA) | ₹2,266.3 Cr | -1.5% | 0.4% | -16.7% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹12,934.7 Cr | -5.8% | -6.3% | 14.7% | Stock Analytics | |
KAVERI SEED COMPANY | ₹6,436.8 Cr | -5.7% | -15.3% | 32.9% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,435.5 Cr | -2% | -1.8% | -33.7% | Stock Analytics | |
MANGALAM GLOBAL ENTERPRISE | ₹481.8 Cr | 3.5% | 11.2% | NA | Stock Analytics | |
INDO US BIOTECH | ₹307.9 Cr | 1.5% | 1.6% | -27% | Stock Analytics |
VENKYS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VENKYS (INDIA) | -1.5% |
0.4% |
-16.7% |
SENSEX | 1.6% |
1% |
7% |
You may also like the below Video Courses